Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 451 participants.

Also called NCT03627884

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 451 participants (enrolled count) (from the registry)
Sponsor
Coney Island Hospital, Brooklyn, NY (from the registry)
Registry
  • NCT NCT03627884
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03627884. Randomized; no masking; primary purpose prevention. Start 2016-10-01 (actual); primary completion 2018-03-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
Condition
End Stage Renal Disease
Condition
Acute Renal Failure
Condition
Hemodialysis Catheter Infection
Condition
Hemodialysis Complication
Condition
Hemodialysis Access Failure
Condition
Hemodialysis Catheter-Associated Bacteremia
Intervention (Drug)
Sodium Bicarbonate Catheter Lock Solution
Intervention (Drug)
Normal Saline Catheter Lock Solution
Lead sponsor
Coney Island Hospital, Brooklyn, NY (class: other)

Record details

Record id
cardio:ct-nct03627884
Content hash
a8ed7b4de2d5d71b7fc824963a6e5f0616b13921f70bf58d7349caf0ab12ee93